These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10664227)

  • 1. Acute respiratory distress syndrome in children with acute iron poisoning: the role of intravenous desferrioxamine.
    Ioannides AS; Panisello JM
    Eur J Pediatr; 2000 Mar; 159(3):158-9. PubMed ID: 10664227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron poisoning.
    Fine JS
    Curr Probl Pediatr; 2000 Mar; 30(3):71-90. PubMed ID: 10742921
    [No Abstract]   [Full Text] [Related]  

  • 3. Pulmonary toxic effects of continuous desferrioxamine administration in acute iron poisoning.
    Tenenbein M; Kowalski S; Sienko A; Bowden DH; Adamson IY
    Lancet; 1992 Mar; 339(8795):699-701. PubMed ID: 1347583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desferrioxamine in acute iron poisoning.
    Chan KW; Bond M; Fernandez W
    Lancet; 1992 Jun; 339(8809):1601-2. PubMed ID: 1351566
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical uses of metal-binding drugs.
    Chenoweth MB
    Clin Pharmacol Ther; 1968; 9(3):365-87. PubMed ID: 4984845
    [No Abstract]   [Full Text] [Related]  

  • 6. Risks of parenteral deferoxamine for acute iron poisoning.
    Howland MA
    J Toxicol Clin Toxicol; 1996; 34(5):491-7. PubMed ID: 8800186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific chelation therapy with desferrioxamine in massive iron overdose.
    Levison LH
    Appl Ther; 1969 Mar; 11(3):153. PubMed ID: 5778632
    [No Abstract]   [Full Text] [Related]  

  • 8. Desferrioxamine in acute iron poisoning.
    Macarol V; Yawalkar SJ
    Lancet; 1992 Jun; 339(8809):1601. PubMed ID: 1351564
    [No Abstract]   [Full Text] [Related]  

  • 9. [Whole bowel irrigation in infants for acute iron poisoning].
    Sokolover N; Rachmel A
    Harefuah; 2000 May; 138(10):837-41, 910. PubMed ID: 10883250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits of parenteral deferoxamine for acute iron poisoning.
    Tenenbein M
    J Toxicol Clin Toxicol; 1996; 34(5):485-9. PubMed ID: 8800185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chelation therapy in beta-thalassemia: the benefits and limitations of desferrioxamine.
    Giardina PJ; Grady RW
    Semin Hematol; 1995 Oct; 32(4):304-12. PubMed ID: 8560288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desferrioxamine in acute iron poisoning.
    Anderson KJ; Rivers RP
    Lancet; 1992 Jun; 339(8809):1602. PubMed ID: 1351567
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnosis and management of acute iron poisoning.
    Reynolds LG
    Baillieres Clin Haematol; 1989 Apr; 2(2):423-33. PubMed ID: 2736312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcutaneous bolus injection of deferoxamine in adult patients affected by onco-hematologic diseases and iron overload.
    Borgna-Pignatti C; Franchini M; Gandini G; Vassanelli A; De Gironcoli M; Aprili G
    Haematologica; 1998 Sep; 83(9):788-90. PubMed ID: 9825575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deferoxamine as a chelating agent.
    Westlin WF
    Clin Toxicol; 1971 Dec; 4(4):597-602. PubMed ID: 5164172
    [No Abstract]   [Full Text] [Related]  

  • 16. Desferrioxamine-chelatable iron (DCI), a component of serum non-transferrin-bound iron (NTBI) used for assessing iron chelation therapy.
    Breuer W; Ermers MJ; Pootrakul P; Abramov A; Hershko C; Cabantchik ZI
    Transfus Sci; 2000 Dec; 23(3):241-2. PubMed ID: 11099901
    [No Abstract]   [Full Text] [Related]  

  • 17. Aluminum intoxication in a child: treatment with intraperitoneal desferrioxamine.
    Warady BA; Ford DM; Gaston CE; Sedman AB; Huffer WE; Lum GM
    Pediatrics; 1986 Oct; 78(4):651-5. PubMed ID: 3763276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival after a severe iron poisoning treated with intermittent infusions of deferoxamine.
    Cheney K; Gumbiner C; Benson B; Tenenbein M
    J Toxicol Clin Toxicol; 1995; 33(1):61-6. PubMed ID: 7837315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The iron chelating agent, deferoxamine detoxifies Fe(Salen)-induced cytotoxicity.
    Umemura M; Kim JH; Aoyama H; Hoshino Y; Fukumura H; Nakakaji R; Sato I; Ohtake M; Akimoto T; Narikawa M; Tanaka R; Fujita T; Yokoyama U; Taguri M; Okumura S; Sato M; Eguchi H; Ishikawa Y
    J Pharmacol Sci; 2017 Aug; 134(4):203-210. PubMed ID: 28779994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of iron chelation therapy with desferrioxamine and deferiprone.
    Cappellini MD; Musallam KM; Taher AT
    Hemoglobin; 2009; 33 Suppl 1():S58-69. PubMed ID: 20001633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.